Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 69-76 , January 2010

Evaluation of DLG2 as a positional candidate for disposition index in African-Americans from the IRAS family study

  • Nicholette D. Palmer

      Affiliations

    • Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • Diabetes Research Center, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • ,
  • Josyf C. Mychaleckyj

      Affiliations

    • Center for Public Health Genomics, University of Virginia, Charlottesville, VA, United States
    • ,
  • Carl. D. Langefeld

      Affiliations

    • Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • ,
  • Julie T. Ziegler

      Affiliations

    • Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • ,
  • Adrienne. H. Williams

      Affiliations

    • Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • ,
  • Michael. Bryer-Ash

      Affiliations

    • Section on Endocrinology and Diabetes, University of Oklahoma, Oklahoma City, OK, United States
    • ,
  • Donald. W. Bowden

      Affiliations

    • Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • Diabetes Research Center, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States
    • Corresponding Author InformationCorresponding author at: Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157, United States. Tel.: +1 336 713 7500; fax: +1 336 713 7566.

Received 9 April 2009 ,Revised 23 September 2009 ,Accepted 26 October 2009.

References 

  1. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46(1):3–19
  2. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 2002;51(suppl. 1):S212–S220
  3. Rich SS, Bergman RN. The genetic basis of glucose homeostasis. Curr. Diab. Rev. 2005;1(3):221–226
  4. Rich SS, Bowden DW, Haffner SM, Norris JM, Saad MF, Mitchell BD, et al. Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 2004;53(7):1866–1875
  5. Palmer ND, Langefeld CD, Campbell JK, Williams AH, Saad M, Norris JM, et al. Genetic mapping of disposition index and acute insulin response loci on chromosome 11q. The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 2006;55(4):911–918
  6. Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, et al. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann. Epidemiol. 2003;13(4):211–217
  7. Steil GM, Volund A, Kahn SE, Bergman RN. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes. 1993;42(2):250–256
  8. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 1979;236(6):E667–E677
  9. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr. Rev. 1985;6(1):45–86
  10. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Methods Programs Biomed. 1986;23(2):113–122
  11. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 2004;74(1):106–120
  12. A haplotype map of the human genome. Nature. 2005;437(7063):1299–1320
  13. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 2001;98(2):581–584
  14. O’Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 1998;63(1):259–266
  15. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265
  16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225–2229
  17. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 1998;62(5):1198–1211
  18. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, et al. A high-resolution recombination map of the human genome. Nat. Genet. 2002;31(3):241–247
  19. de Bakker PI, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005;37(11):1217–1223
  20. Kim E, Cho KO, Rothschild A, Sheng M. Heteromultimerization and NMDA receptor-clustering activity of Chapsyn-110, a member of the PSD-95 family of proteins. Neuron. 1996;17(1):103–113
  21. Schwartz MW. Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity. J. Clin. Invest. 2001;108(7):963–964
  22. Schwartz MW, Porte D. Diabetes, obesity, and the brain. Science. 2005;307(5708):375–379
  23. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 2001;108(7):1079–1085

PII: S0168-8227(09)00463-X

doi: 10.1016/j.diabres.2009.10.015

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 69-76 , January 2010

Article Tools

* Image Usage & Resolution